10 XP 0   0   5  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

BDPT (BioAdaptives Inc) Stock Analysis
Buy, Hold or Sell?

Let's analyze BioAdaptives Inc together

I guess you are interested in BioAdaptives Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – BioAdaptives Inc’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – BioAdaptives Inc’s Price Targets

I'm going to help you getting a better view of BioAdaptives Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about BioAdaptives Inc

I send you an email if I find something interesting about BioAdaptives Inc.

1. Quick Overview

1.1. Quick analysis of BioAdaptives Inc (30 sec.)










1.2. What can you expect buying and holding a share of BioAdaptives Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.00
Expected worth in 1 year
$0.19
How sure are you?
48.6%

+ What do you gain per year?

Total Gains per Share
$0.20
Return On Investment
314.8%

For what price can you sell your share?

Current Price per Share
$0.06
Expected price per share
$0.0405 - $0.1189
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of BioAdaptives Inc (5 min.)




Live pricePrice per Share (EOD)
$0.06
Intrinsic Value Per Share
$-0.06 - $-0.01
Total Value Per Share
$-0.07 - $-0.01

2.2. Growth of BioAdaptives Inc (5 min.)




Is BioAdaptives Inc growing?

Current yearPrevious yearGrowGrow %
How rich?-$1.5m-$1.5m-$123.2k-7.3%

How much money is BioAdaptives Inc making?

Current yearPrevious yearGrowGrow %
Making money-$197.3k-$182.9k-$14.3k-7.3%
Net Profit Margin-6,901.9%-3,129.9%--

How much money comes from the company's main activities?

2.3. Financial Health of BioAdaptives Inc (5 min.)




2.4. Comparing to competitors in the Packaged Foods industry (5 min.)




  Industry Rankings (Packaged Foods)  


Richest
#444 / 458

Most Revenue
#451 / 458

Most Profit
#359 / 458

Most Efficient
#457 / 458
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of BioAdaptives Inc?

Welcome investor! BioAdaptives Inc's management wants to use your money to grow the business. In return you get a share of BioAdaptives Inc.

First you should know what it really means to hold a share of BioAdaptives Inc. And how you can make/lose money.

Speculation

The Price per Share of BioAdaptives Inc is $0.0625. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of BioAdaptives Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in BioAdaptives Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.00. Based on the TTM, the Book Value Change Per Share is $0.05 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.05 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of BioAdaptives Inc.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.00-0.4%-0.01-16.6%-0.02-25.6%-0.01-15.2%-0.01-14.7%-0.01-14.0%
Usd Book Value Change Per Share0.16255.8%0.0578.7%-0.05-77.0%0.003.2%0.004.0%0.000.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.16255.8%0.0578.7%-0.05-77.0%0.003.2%0.004.0%0.000.0%
Usd Price Per Share0.10-0.06-0.00-0.02-0.03-0.11-
Price to Earnings Ratio-104.15--27.30--8.58--12.04--8.42--13.39-
Price-to-Total Gains Ratio0.62-1.12-0.37-0.66-0.20--57.17-
Price to Book Ratio-52.24--13.39--0.45--4.65--3.08--8.96-
Price-to-Total Gains Ratio0.62-1.12-0.37-0.66-0.20--57.17-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0625
Number of shares16000
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.050.00
Usd Total Gains Per Share0.050.00
Gains per Quarter (16000 shares)787.1140.05
Gains per Year (16000 shares)3,148.45160.21
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10314831380160150
20629762860320310
30944594340481470
4012594125820641630
5015742157300801790
6018891188780961950
702203922026011211110
802518825174012821270
902833628322014421430
1003148531470016021590

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%1.036.00.02.7%1.040.00.02.4%
Book Value Change Per Share3.01.00.075.0%9.03.00.075.0%14.06.00.070.0%18.019.00.048.6%20.021.00.048.8%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.037.00.0%0.00.041.00.0%
Total Gains per Share3.01.00.075.0%9.03.00.075.0%14.06.00.070.0%18.019.00.048.6%20.021.00.048.8%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of BioAdaptives Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.1600.049+225%-0.048+130%0.002+7854%0.003+6286%0.000+11860893%
Book Value Per Share---0.002-0.042+2094%-0.097+4947%-0.051+2574%-0.049+2448%-0.037+1811%
Current Ratio--0.0660.062+6%0.052+25%0.045+46%0.043+54%0.102-35%
Debt To Asset Ratio--15.22470.683-78%22.182-31%51.238-70%42.161-64%30.097-49%
Debt To Equity Ratio----0%-0%-0%-0%7.390-100%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value--80430207.70019281770.793+317%-1098621.682+101%5605231.198+1335%3197030.448+2416%3004575.039+2577%
Eps--0.000-0.010+4234%-0.016+6561%-0.009+3854%-0.009+3741%-0.009+3544%
Ev To Ebitda Ratio---80.753-25.260-69%3.278-2564%-4.704-94%-2.437-97%-37.085-54%
Ev To Sales Ratio--504.176-5.830+101%-56.258+111%-60.738+112%-43.125+109%53.802+837%
Free Cash Flow Per Share--0.000-0.003+2281%-0.004+3014%-0.002+1882%-0.002+1475%-0.002+1527%
Free Cash Flow To Equity Per Share--0.0000.003-96%-0.007+5725%-0.001+1232%-0.001+714%0.000+0%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.022-2%1.113-10%
Intrinsic Value_10Y_max---0.010----------
Intrinsic Value_10Y_min---0.064----------
Intrinsic Value_1Y_max---0.007----------
Intrinsic Value_1Y_min---0.009----------
Intrinsic Value_3Y_max---0.016----------
Intrinsic Value_3Y_min---0.025----------
Intrinsic Value_5Y_max---0.020----------
Intrinsic Value_5Y_min---0.039----------
Market Cap565541.250-14412%82072145.70021058224.293+290%550701.818+14803%7265770.031+1030%4716958.898+1640%4034247.364+1934%
Net Profit Margin---4.940-69.019+1297%-31.299+534%-52.336+960%-54.328+1000%-33.512+578%
Operating Margin---10.386-63.725+514%-11.114+7%-31.546+204%-37.524+261%-23.594+127%
Operating Ratio--6.74736.373-81%11.793-43%21.544-69%23.346-71%18.129-63%
Pb Ratio-32.683+37%-52.240-13.390-74%-0.449-99%-4.654-91%-3.077-94%-8.959-83%
Pe Ratio-65.160+37%-104.152-27.296-74%-8.578-92%-12.036-88%-8.420-92%-13.393-87%
Price Per Share0.063-60%0.1000.055+81%0.001+8982%0.019+413%0.026+287%0.113-12%
Price To Free Cash Flow Ratio-131.112+37%-209.569-54.316-74%-2.446-99%-19.299-91%-15.099-93%49.823-521%
Price To Total Gains Ratio0.391-60%0.6251.124-44%0.368+70%0.661-5%0.201+211%-57.173+9249%
Quick Ratio--0.0250.012+106%0.035-28%0.021+20%0.025+1%0.030-15%
Return On Assets---1.784-6.242+250%-2.707+52%-5.928+232%-5.589+213%-4.488+152%
Return On Equity----0%-0%-0%-0%-8.2590%
Total Gains Per Share--0.1600.049+225%-0.048+130%0.002+7854%0.003+6286%0.000+11860893%
Usd Book Value---1571054.000-1690511.250+8%-1567218.5000%-1600323.000+2%-1462902.400-7%-965067.243-39%
Usd Book Value Change Per Share--0.1600.049+225%-0.048+130%0.002+7854%0.003+6286%0.000+11860893%
Usd Book Value Per Share---0.002-0.042+2094%-0.097+4947%-0.051+2574%-0.049+2448%-0.037+1811%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value--80430207.70019281770.793+317%-1098621.682+101%5605231.198+1335%3197030.448+2416%3004575.039+2577%
Usd Eps--0.000-0.010+4234%-0.016+6561%-0.009+3854%-0.009+3741%-0.009+3544%
Usd Free Cash Flow---97906.000-76560.500-22%-61373.250-37%-61441.500-37%-51084.050-48%-44068.108-55%
Usd Free Cash Flow Per Share--0.000-0.003+2281%-0.004+3014%-0.002+1882%-0.002+1475%-0.002+1527%
Usd Free Cash Flow To Equity Per Share--0.0000.003-96%-0.007+5725%-0.001+1232%-0.001+714%0.000+0%
Usd Market Cap565541.250-14412%82072145.70021058224.293+290%550701.818+14803%7265770.031+1030%4716958.898+1640%4034247.364+1934%
Usd Price Per Share0.063-60%0.1000.055+81%0.001+8982%0.019+413%0.026+287%0.113-12%
Usd Profit---197000.000-197363.500+0%-182996.500-7%-194755.500-1%-218157.500+11%-179073.595-9%
Usd Revenue--39882.00010139.250+293%9295.750+329%7729.917+416%6487.000+515%4438.730+799%
Usd Total Gains Per Share--0.1600.049+225%-0.048+130%0.002+7854%0.003+6286%0.000+11860893%
 EOD+1 -7MRQTTM+29 -6YOY+29 -63Y+30 -55Y+31 -510Y+29 -8

3.3 Fundamental Score

Let's check the fundamental score of BioAdaptives Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-65.160
Price to Book Ratio (EOD)Between0-1-32.683
Net Profit Margin (MRQ)Greater than0-4.940
Operating Margin (MRQ)Greater than0-10.386
Quick Ratio (MRQ)Greater than10.025
Current Ratio (MRQ)Greater than10.066
Debt to Asset Ratio (MRQ)Less than115.224
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-1.784
Total1/10 (10.0%)

3.4 Technical Score

Let's check the technical score of BioAdaptives Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5047.317
Ma 20Greater thanMa 500.067
Ma 50Greater thanMa 1000.069
Ma 100Greater thanMa 2000.082
OpenGreater thanClose0.060
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About BioAdaptives Inc

BioAdaptives, Inc. investigates, markets, and distributes natural plant, algal, and mushroom-based products and medical devices for humans and animals. It offers nutraceutical products, such as dietary supplements. The company offers Human Clinical trial; Zeranovia, a natural ingredient and uses proprietary methods of optimizing the availability of nutrients in foods and beverages; Lung Flute, a medical device; and Xcellara, PawPa, and MyndMed. The company was formerly known as APEX 8 Inc. and changed its name to BioAdaptives, Inc. in September 2013. The company was incorporated in 2013 and is based in Las Vegas, Nevada.

Fundamental data was last updated by Penke on 2025-06-27 07:51:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ BioAdaptives Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ BioAdaptives Inc to theΒ Packaged Foods industry mean.
  • A Net Profit Margin of -494.0%Β means thatΒ $-4.94 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of BioAdaptives Inc:

  • The MRQ is -494.0%. The company is making a huge loss. -2
  • The TTM is -6,901.9%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-494.0%TTM-6,901.9%+6,407.9%
TTM-6,901.9%YOY-3,129.9%-3,772.0%
TTM-6,901.9%5Y-5,432.8%-1,469.1%
5Y-5,432.8%10Y-3,351.2%-2,081.6%
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ-494.0%3.5%-497.5%
TTM-6,901.9%3.5%-6,905.4%
YOY-3,129.9%3.3%-3,133.2%
3Y-5,233.6%3.1%-5,236.7%
5Y-5,432.8%3.6%-5,436.4%
10Y-3,351.2%3.6%-3,354.8%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ BioAdaptives Inc is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ BioAdaptives Inc to theΒ Packaged Foods industry mean.
  • -178.4% Return on Assets means thatΒ BioAdaptives Inc generatedΒ $-1.78 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of BioAdaptives Inc:

  • The MRQ is -178.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -624.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-178.4%TTM-624.2%+445.8%
TTM-624.2%YOY-270.7%-353.5%
TTM-624.2%5Y-558.9%-65.2%
5Y-558.9%10Y-448.8%-110.1%
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ-178.4%1.2%-179.6%
TTM-624.2%1.2%-625.4%
YOY-270.7%1.2%-271.9%
3Y-592.8%1.2%-594.0%
5Y-558.9%1.2%-560.1%
10Y-448.8%1.2%-450.0%
4.3.1.3. Return on Equity

Shows how efficient BioAdaptives Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ BioAdaptives Inc to theΒ Packaged Foods industry mean.
  • 0.0% Return on Equity means BioAdaptives Inc generated $0.00Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of BioAdaptives Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-825.9%+825.9%
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.6%-2.6%
TTM-2.4%-2.4%
YOY-2.5%-2.5%
3Y-2.4%-2.4%
5Y-2.6%-2.6%
10Y-825.9%2.7%-828.6%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of BioAdaptives Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient BioAdaptives Inc is operatingΒ .

  • Measures how much profit BioAdaptives Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ BioAdaptives Inc to theΒ Packaged Foods industry mean.
  • An Operating Margin of -1,038.6%Β means the company generated $-10.39 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of BioAdaptives Inc:

  • The MRQ is -1,038.6%. The company is operating very inefficient. -2
  • The TTM is -6,372.5%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-1,038.6%TTM-6,372.5%+5,333.9%
TTM-6,372.5%YOY-1,111.4%-5,261.2%
TTM-6,372.5%5Y-3,752.4%-2,620.1%
5Y-3,752.4%10Y-2,359.4%-1,393.0%
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ-1,038.6%4.8%-1,043.4%
TTM-6,372.5%4.5%-6,377.0%
YOY-1,111.4%4.0%-1,115.4%
3Y-3,154.6%3.1%-3,157.7%
5Y-3,752.4%3.9%-3,756.3%
10Y-2,359.4%4.8%-2,364.2%
4.3.2.2. Operating Ratio

Measures how efficient BioAdaptives Inc is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Packaged Foods industry mean).
  • An Operation Ratio of 6.75 means that the operating costs are $6.75 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of BioAdaptives Inc:

  • The MRQ is 6.747. The company is inefficient in keeping operating costs low. -1
  • The TTM is 36.373. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ6.747TTM36.373-29.626
TTM36.373YOY11.793+24.580
TTM36.3735Y23.346+13.027
5Y23.34610Y18.129+5.218
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ6.7471.535+5.212
TTM36.3731.426+34.947
YOY11.7931.089+10.704
3Y21.5441.205+20.339
5Y23.3461.140+22.206
10Y18.1291.055+17.074
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of BioAdaptives Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if BioAdaptives Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Packaged Foods industry mean).
  • A Current Ratio of 0.07Β means the company has $0.07 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of BioAdaptives Inc:

  • The MRQ is 0.066. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.062. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.066TTM0.062+0.004
TTM0.062YOY0.052+0.009
TTM0.0625Y0.043+0.019
5Y0.04310Y0.102-0.059
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0661.520-1.454
TTM0.0621.517-1.455
YOY0.0521.570-1.518
3Y0.0451.605-1.560
5Y0.0431.642-1.599
10Y0.1021.666-1.564
4.4.3.2. Quick Ratio

Measures if BioAdaptives Inc is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ BioAdaptives Inc to theΒ Packaged Foods industry mean.
  • A Quick Ratio of 0.03Β means the company can pay off $0.03 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of BioAdaptives Inc:

  • The MRQ is 0.025. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.012. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.025TTM0.012+0.013
TTM0.012YOY0.035-0.023
TTM0.0125Y0.025-0.013
5Y0.02510Y0.030-0.005
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0250.526-0.501
TTM0.0120.534-0.522
YOY0.0350.661-0.626
3Y0.0210.662-0.641
5Y0.0250.681-0.656
10Y0.0300.771-0.741
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of BioAdaptives Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of BioAdaptives IncΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ BioAdaptives Inc to Packaged Foods industry mean.
  • A Debt to Asset Ratio of 15.22Β means that BioAdaptives Inc assets areΒ financed with 1,522.4% credit (debt) and the remaining percentage (100% - 1,522.4%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of BioAdaptives Inc:

  • The MRQ is 15.224. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 70.683. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ15.224TTM70.683-55.458
TTM70.683YOY22.182+48.500
TTM70.6835Y42.161+28.522
5Y42.16110Y30.097+12.064
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ15.2240.468+14.756
TTM70.6830.476+70.207
YOY22.1820.473+21.709
3Y51.2380.479+50.759
5Y42.1610.483+41.678
10Y30.0970.483+29.614
4.5.4.2. Debt to Equity Ratio

Measures ifΒ BioAdaptives Inc is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ BioAdaptives Inc to theΒ Packaged Foods industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of BioAdaptives Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y7.390-7.390
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.886-0.886
TTM-0.921-0.921
YOY-0.896-0.896
3Y-0.942-0.942
5Y-0.952-0.952
10Y7.3901.025+6.365
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings BioAdaptives Inc generates.

  • Above 15 is considered overpriced butΒ always compareΒ BioAdaptives Inc to theΒ Packaged Foods industry mean.
  • A PE ratio of -104.15 means the investor is paying $-104.15Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of BioAdaptives Inc:

  • The EOD is -65.160. Based on the earnings, the company is expensive. -2
  • The MRQ is -104.152. Based on the earnings, the company is expensive. -2
  • The TTM is -27.296. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-65.160MRQ-104.152+38.992
MRQ-104.152TTM-27.296-76.856
TTM-27.296YOY-8.578-18.719
TTM-27.2965Y-8.420-18.876
5Y-8.42010Y-13.393+4.973
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
EOD-65.16013.710-78.870
MRQ-104.15212.832-116.984
TTM-27.29612.675-39.971
YOY-8.57813.166-21.744
3Y-12.03614.926-26.962
5Y-8.42016.184-24.604
10Y-13.39318.972-32.365
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of BioAdaptives Inc:

  • The EOD is -131.112. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -209.569. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -54.316. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-131.112MRQ-209.569+78.457
MRQ-209.569TTM-54.316-155.253
TTM-54.316YOY-2.446-51.870
TTM-54.3165Y-15.099-39.218
5Y-15.09910Y49.823-64.921
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
EOD-131.1125.462-136.574
MRQ-209.5694.843-214.412
TTM-54.3164.051-58.367
YOY-2.4463.957-6.403
3Y-19.2992.698-21.997
5Y-15.0991.480-16.579
10Y49.8231.818+48.005
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ BioAdaptives Inc is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Packaged Foods industry mean).
  • A PB ratio of -52.24 means the investor is paying $-52.24Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of BioAdaptives Inc:

  • The EOD is -32.683. Based on the equity, the company is expensive. -2
  • The MRQ is -52.240. Based on the equity, the company is expensive. -2
  • The TTM is -13.390. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-32.683MRQ-52.240+19.557
MRQ-52.240TTM-13.390-38.850
TTM-13.390YOY-0.449-12.940
TTM-13.3905Y-3.077-10.313
5Y-3.07710Y-8.959+5.882
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
EOD-32.6831.387-34.070
MRQ-52.2401.284-53.524
TTM-13.3901.389-14.779
YOY-0.4491.517-1.966
3Y-4.6541.634-6.288
5Y-3.0771.828-4.905
10Y-8.9592.410-11.369
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets110
Total Liabilities1,682
Total Stockholder Equity-1,571
 As reported
Total Liabilities 1,682
Total Stockholder Equity+ -1,571
Total Assets = 110

Assets

Total Assets110
Total Current Assets110
Long-term Assets0
Total Current Assets
Cash And Cash Equivalents 40
Net Receivables 3
Inventory 41
Other Current Assets 30
Total Current Assets  (as reported)110
Total Current Assets  (calculated)113
+/- 3
Long-term Assets
Long-term Assets  (as reported)0
Long-term Assets  (calculated)0
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities1,682
Long-term Liabilities0
Total Stockholder Equity-1,571
Total Current Liabilities
Short-term Debt 343
Short Long Term Debt 343
Accounts payable 6
Other Current Liabilities 1,338
Total Current Liabilities  (as reported)1,682
Total Current Liabilities  (calculated)2,031
+/- 349
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock1
Retained Earnings -9,360
Other Stockholders Equity 7,788
Total Stockholder Equity (as reported)-1,571
Total Stockholder Equity (calculated)-1,571
+/-0
Other
Capital Stock1
Cash and Short Term Investments 40
Common Stock Shares Outstanding 821,543
Liabilities and Stockholders Equity 110
Net Debt 304
Net Invested Capital -1,228
Net Working Capital -1,571
Short Long Term Debt Total 343



6.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-09-302014-06-302014-03-312013-09-302013-06-30
> Total Assets 
0
0
193
72
99
32
13
8
7
155
149
156
147
139
0
0
0
0
0
0
110
32
21
14
24
27
22
32
19
122
136
179
149
87
69
30
37
13
48
329
104
59
9
46
262
110
110262469591043294813373069871491791361221932222724142132110000000139147156149155781332997219300
   > Total Current Assets 
0
0
193
71
98
31
12
7
7
154
149
156
147
139
0
0
0
4
0
0
110
32
21
14
24
27
22
32
19
41
81
77
89
61
61
26
34
11
47
163
89
41
9
46
262
110
1102624694189163471134266161897781411932222724142132110004000139147156149154771231987119300
       Cash And Cash Equivalents 
0
0
13
9
40
4
0
0
0
0
0
12
8
0
0
0
0
-4
0
0
56
19
12
0
12
12
4
14
5
24
70
66
83
56
50
18
25
6
40
152
61
20
0
44
137
40
401374402061152406251850568366702451441212012195600-400008120000044091300
       Short-term Investments 
0
0
180
61
32
27
11
5
7
6
3
3
4
4
0
0
0
7
0
0
4
2
2
1
1
0
0
0
0
3
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000001300001122400700044336751127326118000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3
0
0
0
0
0
3
3000003000000000000000000000000000000000000000
       Other Current Assets 
0
0
0
0
26
2
2
2
0
4
2
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
0
1
1
1
1
0
0
0
0
0
0
3
3
3
0
30
300333000000111102000000000000000002240222260000
   > Long-term Assets 
0
0
0
1
1
1
1
1
0
0
0
0
0
0
0
0
0
-4
0
0
0
0
0
0
0
0
0
0
0
81
55
101
60
27
8
4
3
2
2
167
15
18
0
0
0
0
00001815167223482760101558100000000000-400000000011111000
       Property Plant Equipment 
0
0
0
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000000000111111000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
81
55
101
60
27
8
4
3
2
2
167
15
18
0
0
0
0
00001815167223482760101558100000000000000000000000000000
       Other Assets 
0
0
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000000000000000200
> Total Liabilities 
0
1
33
60
138
57
150
176
211
280
297
316
323
319
0
0
0
0
0
0
804
612
760
785
864
1,011
1,347
1,285
1,398
1,165
1,488
1,391
1,242
1,485
1,564
1,625
1,489
1,644
1,727
1,475
1,751
1,857
1,930
1,852
1,726
1,682
1,6821,7261,8521,9301,8571,7511,4751,7271,6441,4891,6251,5641,4851,2421,3911,4881,1651,3981,2851,3471,01186478576061280400000031932331629728021117615057138603310
   > Total Current Liabilities 
0
1
33
60
138
57
150
176
211
280
297
316
323
319
0
0
0
0
0
0
716
485
742
785
864
1,011
1,347
1,285
1,398
1,165
1,488
1,391
1,242
1,485
1,564
1,625
1,489
1,644
1,727
1,475
1,751
1,857
1,930
1,852
1,726
1,682
1,6821,7261,8521,9301,8571,7511,4751,7271,6441,4891,6251,5641,4851,2421,3911,4881,1651,3981,2851,3471,01186478574248571600000031932331629728021117615057138603310
       Short-term Debt 
0
0
0
0
34
34
0
0
0
0
0
0
0
272
0
0
0
0
0
0
0
10
162
240
0
453
425
464
483
445
523
480
437
427
450
434
392
358
377
333
0
321
350
343
0
343
343034335032103333773583924344504274374805234454834644254530240162100000000272000000034340000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
162
240
370
453
425
464
483
445
523
480
437
427
450
434
392
358
377
333
329
321
350
350
343
343
3433433503503213293333773583924344504274374805234454834644254533702401620000000000000000000000
       Accounts payable 
0
1
1
11
18
18
64
34
34
17
10
12
3
0
0
0
0
0
0
0
40
0
3
0
1
0
10
1
5
1
1
1
2
8
3
5
7
2
1
5
3
3
3
9
6
6
669333512753821115110010304000000003121017343464181811110
       Other Current Liabilities 
0
0
32
49
35
39
86
142
151
263
287
303
320
48
0
0
0
0
0
0
676
475
577
545
484
558
912
820
909
718
964
910
803
1,050
1,112
1,186
1,090
1,284
1,348
1,137
978
1,533
1,577
1,509
1,053
1,338
1,3381,0531,5091,5771,5339781,1371,3481,2841,0901,1861,1121,05080391096471890982091255848454557747567600000048320303287263151142863935493200
   > Long-term Liabilities 
0
1
1
11
104
18
64
34
0
17
10
12
0
0
0
0
0
0
0
0
88
127
18
240
0
453
435
465
488
446
524
481
439
435
453
439
399
347
0
0
0
0
0
0
0
0
000000003473994394534354394815244464884654354530240181278800000000121017034641810411110
> Total Stockholder Equity
0
-1
160
12
-40
-25
-137
-168
-203
-125
-148
-160
-176
-181
0
0
0
4
0
0
-694
-580
-739
-771
-840
-984
-1,324
-1,253
-1,379
-1,043
-1,352
-1,212
-1,093
-1,398
-1,495
-1,596
-1,452
-1,631
-1,679
-1,146
-1,647
-1,798
-1,922
-1,805
-1,464
-1,571
-1,571-1,464-1,805-1,922-1,798-1,647-1,146-1,679-1,631-1,452-1,596-1,495-1,398-1,093-1,212-1,352-1,043-1,379-1,253-1,324-984-840-771-739-580-694004000-181-176-160-148-125-203-168-137-25-4012160-10
   Common Stock
1
1
1
1
1
1
1
1
1
1
1
1
1
1
0
0
0
0
0
0
2
2
2
2
2
2
2
2
2
3
3
4
5
6
8
13
25
38
58
78
0
115
123
123
0
1
101231231150785838251386543322222222200000011111111111111
   Retained Earnings -9,360-9,163-8,792-8,754-8,571-8,264-7,996-7,983-7,839-7,552-7,523-7,247-7,023-6,656-6,442-6,407-6,098-5,606-5,441-5,427-4,997-4,759-4,662-4,607-4,428-4,520000000-3,002-2,992-2,962-2,935-2,902-2,821-2,773-2,732-2,623-295-273-27-2-1
   Capital Surplus 0000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
1
206
283
283
2,632
2,645
2,659
-57
2,831
2,845
2,859
2,873
2,878
0
0
0
0
0
0
3,824
3,845
3,866
3,890
0
4,010
4,101
4,186
4,225
5,052
5,052
5,226
5,558
5,619
5,744
5,914
6,075
6,170
6,246
6,772
0
6,657
6,708
6,863
0
7,788
7,78806,8636,7086,65706,7726,2466,1706,0755,9145,7445,6195,5585,2265,0525,0524,2254,1864,1014,01003,8903,8663,8453,8240000002,8782,8732,8592,8452,831-572,6592,6452,63228328320610



6.3. Balance Sheets

Currency in USD. All numbers in thousands.




6.4. Cash Flows

Currency in USD. All numbers in thousands.




6.5. Income Statements

Currency in USD. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue13
Cost of Revenue-9
Gross Profit44
 
Operating Income (+$)
Gross Profit4
Operating Expense-597
Operating Income-602-593
 
Operating Expense (+$)
Research Development0
Selling General Administrative505
Selling And Marketing Expenses0
Operating Expense597505
 
Net Interest Income (+$)
Interest Income0
Interest Expense-92
Other Finance Cost-0
Net Interest Income-92
 
Pretax Income (+$)
Operating Income-602
Net Interest Income-92
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-905-299
EBIT - interestExpense = -1,089
-905
-807
Interest Expense92
Earnings Before Interest and Taxes (EBIT)-997-813
Earnings Before Interest and Taxes (EBITDA)-602
 
After tax Income (+$)
Income Before Tax-905
Tax Provision-0
Net Income From Continuing Ops-905-905
Net Income-899
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses615
Total Other Income/Expenses Net-30392
 

Technical Analysis of BioAdaptives Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of BioAdaptives Inc. The general trend of BioAdaptives Inc is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine BioAdaptives Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. BioAdaptives Inc Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of BioAdaptives Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.09 < 0.1165 < 0.1189.

The bearish price targets are: 0.041 > 0.0408 > 0.0405.

Know someone who trades $BDPT? Share this with them.πŸ‘‡

BioAdaptives Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of BioAdaptives Inc. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

BioAdaptives Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of BioAdaptives Inc. The current macd is -0.00054951.

The long score for the Moving Average Convergence/Divergence (MACD) is 2/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 0/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the BioAdaptives Inc price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for BioAdaptives Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the BioAdaptives Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
BioAdaptives Inc Daily Moving Average Convergence/Divergence (MACD) ChartBioAdaptives Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of BioAdaptives Inc. The current adx is 20.55.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell BioAdaptives Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
BioAdaptives Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of BioAdaptives Inc. The current sar is 0.03545316.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
BioAdaptives Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of BioAdaptives Inc. The current rsi is 47.32. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
BioAdaptives Inc Daily Relative Strength Index (RSI) ChartBioAdaptives Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of BioAdaptives Inc. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -1/(-6 +6).

  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the BioAdaptives Inc price going down in the near term. -2
  • Trending up: The STOCH %K is trending up. +1
BioAdaptives Inc Daily Stochastic Oscillator ChartBioAdaptives Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of BioAdaptives Inc. The current cci is -62.77338344.

BioAdaptives Inc Daily Commodity Channel Index (CCI) ChartBioAdaptives Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of BioAdaptives Inc. The current cmo is -7.75884205.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
BioAdaptives Inc Daily Chande Momentum Oscillator (CMO) ChartBioAdaptives Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of BioAdaptives Inc. The current willr is -50.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that BioAdaptives Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
BioAdaptives Inc Daily Williams %R ChartBioAdaptives Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of BioAdaptives Inc.

BioAdaptives Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of BioAdaptives Inc. The current atr is 0.01493881.

BioAdaptives Inc Daily Average True Range (ATR) ChartBioAdaptives Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of BioAdaptives Inc. The current obv is 51,714,653.

BioAdaptives Inc Daily On-Balance Volume (OBV) ChartBioAdaptives Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of BioAdaptives Inc. The current mfi is 40.80.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
BioAdaptives Inc Daily Money Flow Index (MFI) ChartBioAdaptives Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for BioAdaptives Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-20STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-24CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-02-25STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-03-03CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-03-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-10STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-17STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-03-18STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-24STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-25CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-26STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-03-31STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-04-02STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-03CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-04STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-07CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-08STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-10STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-15CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-16STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-04-17MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-04-21STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-04-22STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-04-23STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-25STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-04-29STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-05-01STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-05-06WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-05-07STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-05-09STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-05-12MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-05-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-05-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-05-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-16STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-20CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-05-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-23STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-06-03STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-04STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-05STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-06-09STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-06-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-06-13CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-06-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-06-17SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-06-18STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-24CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-26STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-30STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-07-09WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-07-11STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

BioAdaptives Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of BioAdaptives Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5047.317
Ma 20Greater thanMa 500.067
Ma 50Greater thanMa 1000.069
Ma 100Greater thanMa 2000.082
OpenGreater thanClose0.060
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of BioAdaptives Inc with someone you think should read this too:
  • Are you bullish or bearish on BioAdaptives Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about BioAdaptives Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about BioAdaptives Inc

I send you an email if I find something interesting about BioAdaptives Inc.


Comments

How you think about this?

Leave a comment

Stay informed about BioAdaptives Inc.

Receive notifications about BioAdaptives Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.